Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To test whether naltrexone compared to placebo can reduce heavy drinking and improve smoking
cessation outcomes in heavy drinkers seeking smoking cessation treatment.